Journal article
Phase II clinical trial of carboplatin and docetaxel in patients with metastatic ovarian cancer: Active combination with low incidence of peripheral neuropathy
Abstract
Vorobiof DA, Rapoport BL, Chasen MR, Cohen GL, Mahomed R, Karime M. Phase II clinical trial of carboplatin and docetaxel in patients with metastatic ovarian cancer: Active combination with low incidence of peripheral neuropathy. Int J Gynecol Cancer 2003;13:287–291. During the past 2 decades there have been chemotherapeutic advances in the management of patients with advanced epithelial ovarian cancer. Nevertheless, new drug combinations aimed …
Authors
Vorobiof DA; Rapoport BL; Chasen MR; Cohen GL; Mahomed R; Karime M
Journal
International Journal of Gynecological Cancer, Vol. 13, No. 3, pp. 287–291
Publisher
Elsevier
Publication Date
May 2003
DOI
10.1136/ijgc-00009577-200305000-00004
ISSN
1048-891X